Caplyta in Borderline Personality Disorder | MicrobiomeTrials← Back to trialsNCT05356013
Caplyta in Borderline Personality Disorder
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2023-05-10Est. Completion: 2025-12-31
Enrollment target: 60 participants Locations- University of Chicago Medical Center, Chicago, Illinois, United States
Other microbiome trials you might be interested in
Borderline Personality Disorder (BPD)
This study is a mixed-methods, single-arm cross-sectional study comprising 1) a qualitative, exploratory, critical-const…
Heidelberg, GermanyEst. completion Dec 31, 2026
Borderline Personality Disorder
The purpose of this study is to test the ability of mindfulness-based real time functional magnetic resonance imaging (f…
New Haven, United StatesEst. completion Oct 30, 2026